Spending on direct-to-consumer advertising increased by 296.4% from 1997 to 2005, during which time spending on promotion to physicians increased by 86.0% and spending on pharmaceutical research and development increased by 103.3%. Data are from the Government Accountability Office (report no. GAO-07-54, December 14, 2006).Click here to read the article (registration required).
Wednesday, May 30, 2007
Check out the latest issue of the New England Journal of Medicine for the free full-text article "Drug Risks and Free Speech — Can Congress Ban Consumer Drug Ads?" From the article: